Pressure BioSciences, Inc. (OTCQB: PBIO) announced that Zacks Small Cap Research (“Zacks SCR”) has initiated coverage on the Company. Pressure BioSciences, Inc. is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our primary focus is in the development of PCT-based products for biomarker and […]

Pressure BioSciences, Inc. (OTCQB: PBIO) announced the Company’s patented pressure cycling technology (“PCT”) platform was featured as an integral part of a new, innovative workflow for the analysis of proteins from cancer biopsy samples. This workflow was presented in a plenary session at the Annual Meeting of the International Gynecologic Cancer Society (“IGCS”) on September […]

Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences and other industries. The Company announced today the publication of two scientific journal articles, led by independent teams of scientists in China and Australia, […]

Pressure BioSciences, Inc. (OTCQB: PBIO) announced the launch of its BaroShear K45 system based on the Company’s proprietary Ultra Shear Technology platform. The BaroShear K45 system is a unique and powerful next generation nanoemulsification system designed to fix one of the most critical problems facing CBD manufacturers today: the extremely poor water solubility of CBD […]

Pressure BioSciences, Inc. (OTCQB: PBIO) announced that the Company’s patented pressure cycling technology platform was prominently featured in 15 independent presentations at the annual conference of the American Society for Mass Spectrometry, held from June 1-6, 2019 in Atlanta, GA. The presentations spanned wide ranging applications for PBI’s unique PCT platform in scientific studies, particularly […]